We are working on the following new projects:

• We signed the contract for the development of a scientific article based on the results of the observation program in chronic hepatitis C genotypes 1 to 6 in CEE.
• Smooth is starting medical writing activities for bioequivalence clinical trial with INN: Oxyethylammonium methylphenoxiacetate.
• We signed the contract for data management activities for a bioequivalence clinical trial with INN: Paroxetinum.
• We were awarded with a trial in general anxiety disorder by our long-term Russian client.

We are happy to reach the following milestones in our projects:

• We are finishing the monitoring in the Dalteparin and Paliperidon trails.
• We received the MOH’s approval in the Covid-19 vaccine trial.